Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARMYDA-AMULET: SAPT vs DAPT After Percutaneous LAA Closure
NCT05554822Phase 3Unknown
- Sponsor
- Azienda Ospedaliero-Universitaria Maggiore della Carità
- Start
- Jun 2021
- Primary completion
- Dec 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of aspirin in Atrial fibrillation (AFib), sponsored by Azienda Ospedaliero-Universitaria Maggiore della Carità. Status: unknown.
02
Drugs
aspirin
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT05554822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05554822.